SCI Pharmtech Inc (4119) — Financial Flexibility Index
SCI Pharmtech Inc (4119) has a Financial Flexibility Index of 0.11x as of December 2025. Free cash flow of NT$160.93 Million (operating CF NT$62.91 Million minus capex NT$98.02 Million) represents 0% of total liabilities (NT$1.49 Billion). Also explore SCI Pharmtech Inc annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
SCI Pharmtech Inc Financial Flexibility Index (2002–2025)
Historical Financial Flexibility Index trend for SCI Pharmtech Inc across 23 annual periods. Check SCI Pharmtech Inc strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for SCI Pharmtech Inc (2002–2025)
Year-by-year free cash flow to debt coverage for SCI Pharmtech Inc. For the full company profile including market capitalisation, see SCI Pharmtech Inc (4119) total market value.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.56x | NT$830.32 Million | NT$220.32 Million | NT$1.49 Billion | ▼ -46.9% |
| 2024 | 1.05x | NT$1.81 Billion | NT$860.52 Million | NT$1.72 Billion | ▲ +33.9% |
| 2023 | 0.78x | NT$1.25 Billion | NT$215.77 Million | NT$1.59 Billion | ▼ -28.8% |
| 2022 | 1.10x | NT$1.46 Billion | NT$296.56 Million | NT$1.33 Billion | ▼ -9.4% |
| 2021 | 1.21x | NT$1.06 Billion | NT$280.28 Million | NT$869.26 Million | ▲ +27.4% |
| 2020 | 0.95x | NT$1.19 Billion | NT$971.53 Million | NT$1.25 Billion | ▼ -41.9% |
| 2019 | 1.64x | NT$996.08 Million | NT$791.60 Million | NT$606.84 Million | ▲ +47.9% |
| 2018 | 1.11x | NT$642.63 Million | NT$480.18 Million | NT$578.85 Million | ▼ -5.3% |
| 2017 | 1.17x | NT$429.04 Million | NT$281.65 Million | NT$365.88 Million | ▼ -17.2% |
| 2016 | 1.42x | NT$679.31 Million | NT$502.11 Million | NT$479.43 Million | ▲ +11.8% |
| 2015 | 1.27x | NT$880.75 Million | NT$663.24 Million | NT$695.02 Million | ▲ +73.2% |
| 2014 | 0.73x | NT$727.92 Million | NT$358.77 Million | NT$994.64 Million | ▼ -28.8% |
| 2013 | 1.03x | NT$1.01 Billion | NT$238.57 Million | NT$984.62 Million | ▼ -41.8% |
| 2012 | 1.76x | NT$566.47 Million | NT$385.57 Million | NT$321.12 Million | ▲ +71.1% |
| 2011 | 1.03x | NT$397.26 Million | NT$249.55 Million | NT$385.26 Million | ▼ -5.9% |
| 2010 | 1.10x | NT$409.30 Million | NT$218.96 Million | NT$373.37 Million | ▼ -52.8% |
| 2009 | 2.32x | NT$498.09 Million | NT$316.96 Million | NT$214.32 Million | ▲ +15.3% |
| 2008 | 2.02x | NT$383.42 Million | NT$245.29 Million | NT$190.16 Million | ▲ +6.5% |
| 2007 | 1.89x | NT$334.74 Million | NT$167.53 Million | NT$176.74 Million | ▼ -38.8% |
| 2006 | 3.09x | NT$293.62 Million | NT$131.62 Million | NT$94.94 Million | ▲ +255.8% |
| 2004 | 0.87x | NT$112.16 Million | NT$76.61 Million | NT$129.03 Million | ▼ -70.9% |
| 2003 | 2.98x | NT$307.15 Million | NT$206.86 Million | NT$102.99 Million | ▲ +416.4% |
| 2002 | 0.58x | NT$148.85 Million | NT$107.12 Million | NT$257.76 Million | — |